344 publications have been identified in PubMed for intrahepatic cholangiocarcinoma. Research spans Basic Science / Preclinical (30%), Review / Meta-Analysis (25%), and Diagnostic / Biomarker (15%).

Recent Publications

• Beaufrère A (2026). [PMID: 41541502](https://pubmed.ncbi.nlm.nih.gov/41541502/). *JHEP Rep*. [Diagnostic / Biomarker]

• Ma Y (2026). [PMID: 41519216](https://pubmed.ncbi.nlm.nih.gov/41519216/). *Cell Signal*. [Gene Therapy / Novel Therapeutics]

• Yang X (2026). [PMID: 42169873](https://pubmed.ncbi.nlm.nih.gov/42169873/). *J Gastrointest Oncol*. [Epidemiology / Natural History]

• Machado MA (2026). [PMID: 41530598](https://pubmed.ncbi.nlm.nih.gov/41530598/). *Ann Surg Oncol*. [Case Report / Case Series]

• Georgiades C (2026). [PMID: 41528229](https://pubmed.ncbi.nlm.nih.gov/41528229/). *Radiology*. [Other]

• Vanterpool G Jr (2026). [PMID: 42186986](https://pubmed.ncbi.nlm.nih.gov/42186986/). *Am Surg*. [Clinical Trial Publication]

• He X (2026). [PMID: 40603768](https://pubmed.ncbi.nlm.nih.gov/40603768/). *Eur Radiol*. [Epidemiology / Natural History]

• Zhou X (2026). [PMID: 41628547](https://pubmed.ncbi.nlm.nih.gov/41628547/). *Eur J Surg Oncol*. [Diagnostic / Biomarker]

• Arya S (2026). [PMID: 42243894](https://pubmed.ncbi.nlm.nih.gov/42243894/). *J Exp Clin Cancer Res*. [Gene Therapy / Novel Therapeutics]

• Oyenuga M (2026). [PMID: 42169949](https://pubmed.ncbi.nlm.nih.gov/42169949/). *J Gastrointest Oncol*. [Other]